Kolexia
Loirat Chantal
Médecine générale
Hôpital Robert-Debré
Paris, France
122 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome hémolytique et urémique Syndrome hémolytique et urémique atypique Microangiopathies thrombotiques Défaillance rénale chronique Insuffisance rénale Maladies du rein Hémolyse Syndrome néphrotique Prédisposition génétique à une maladie

Industries

Roche
5 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

History of pediatric nephrology in France.
Medecine sciences : M/S   21 mars 2023
POS-052 TWO PHASE III TRIALS EVALUATING CROVALIMAB IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (aHUS): COMMUTE-a and COMMUTE-p
The ISN Frontiers Meeting “Complement-Related Kidney Diseases: Classification, Genetics, and Treatment” Abstracts 2022   01 juin 2022
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
Blood   07 décembre 2021
Histoire de la dialyse en pédiatrie
Perfectionnement en Pédiatrie   27 juillet 2021
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Blood   22 mars 2021
Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing , an overview of 10 years of surveillance in France, 2007 to 2016.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   16 juillet 2020
STOPECU: Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Essai Clinique (CHU Nantes)   05 décembre 2019
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.
Journal of the American Society of Nephrology : JASN   01 octobre 2019
Complement Gene Variants and Shiga Toxin-Producing -Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.
Clinical journal of the American Society of Nephrology : CJASN   23 janvier 2019
Growing Frequency of Transplanted Patients Among the French Cohort of Atypical Hemolytic Uremic Syndrome in the Era of Eculizumab
Abstracts of the 18\u003csup\u003eth\u003c/sup\u003e Annual Congress of the French Speaking Transplantation Society, Toulouse, France, 4‐7 December 2018   26 décembre 2018